Bowyer, Annette E.
443  results:
Search for persons X
?
1

The combination of emicizumab and recombinant factor VIII i..:

Bowyer, Annette E. ; Maclean, Rhona M. ; Kitchen, Steve
International Journal of Laboratory Hematology.  45 (2023)  3 - p. 368-376 , 2023
 
?
2

Agreement between one stage and chromogenic assays in sampl..:

Guy, Susan ; Bowyer, Annette E. ; Shepherd, M. Fiona..
International Journal of Laboratory Hematology.  46 (2023)  1 - p. 135-140 , 2023
 
?
3

Factor VIII and Factor IX Activity Measurements for Hemophi..:

Bowyer, Annette E. ; Gosselin, Robert C.
Seminars in Thrombosis and Hemostasis.  49 (2022)  6 - p. 609-620 , 2022
 
?
4

How to assess parallelism in factor assays: coefficient of ..:

Guy, Susan ; Shepherd, M. Fiona ; Bowyer, Annette E..
International Journal of Laboratory Hematology.  45 (2022)  2 - p. 229-240 , 2022
 
?
6

A cost‐effective approach to factor assay calibration using..:

Guy, Susan ; Sermon‐Cadd, Anne M. ; Shepherd, Fiona M...
International Journal of Laboratory Hematology.  41 (2019)  5 - p. 679-683 , 2019
 
?
7

Evaluation of a semi‐automated von Willebrand factor multim..:

Bowyer, Annette E. ; Goodfellow, Karen J. ; Seidel, Holger...
Research and Practice in Thrombosis and Haemostasis.  2 (2018)  4 - p. 790-799 , 2018
 
?
8

Measurement of extended half‐life recombinant factor IX pro..:

Bowyer, Annette E. ; Shepherd, M. Fiona ; Kitchen, Steve..
International Journal of Laboratory Hematology.  41 (2018)  2 - p. , 2018
 
?
9

p.Tyr365Cys change in factor VIII: haemophilia A, but not a..:

Bowyer, Annette E. ; Goodeve, Anne ; Liesner, Ri...
British Journal of Haematology.  154 (2011)  5 - p. 618-625 , 2011
 
1-15